Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

HPV PATRICIA Study Group

    Research output: Contribution to journalArticleScientificpeer-review

    364 Citations (Scopus)
    Original languageEnglish
    Pages (from-to)100-110
    JournalLANCET ONCOLOGY
    Volume13
    Issue number1
    DOIs
    Publication statusPublished - 2012
    Publication typeA1 Journal article-refereed

    Keywords

    • human papillomavirus

    Publication forum classification

    • Publication forum level 3

    Cite this